HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean Michel Cayuela Selected Research
Jean Michel Cayuela Research Topics
Disease
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2014 - 01/2007
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 01/2019
1
Philadelphia Chromosome
12/2021
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019
1
Eosinophilia
05/2014
1
Bronchiolitis Obliterans Syndrome
05/2014
1
Drug Hypersensitivity Syndrome
05/2014
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
09/2013
1
Blast Crisis (Blast Phase)
06/2011
1
T-Cell Lymphoma (Lymphoma, T Cell)
05/2008
1
Congenital Diaphragmatic Hernias
01/2005
Drug/Important Bio-Agent (IBA)
5
Imatinib Mesylate (Gleevec)
FDA Link
02/2014 - 01/2007
3
Tyrosine Kinase Inhibitors
IBA
02/2014 - 06/2011
2
Biological Products
IBA
01/2019 - 05/2014
1
ponatinib
IBA
12/2021
1
asciminib
IBA
12/2021
1
Protein Tyrosine Phosphatases
IBA
01/2019
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2019
1
Epitopes
IBA
05/2014
1
Interleukin-17 (Interleukin 17)
IBA
05/2014
1
Dasatinib (BMS 354825)
FDA Link
11/2012
1
KIR Receptors
IBA
11/2012
1
Cytarabine (Cytosar-U)
FDA Link
Generic
06/2011
1
Daunorubicin (Cerubidine)
FDA Link
Generic
06/2011
1
Endothelin Receptors (Endothelin Receptor)
IBA
01/2005
Therapy/Procedure
2
Therapeutics
02/2014 - 11/2012
1
Aftercare (After-Treatment)
05/2008